dihexa pnb-0408 human trial (PNB-0408) — Dosing, Side Effects, FDA Status & Research | PeptIQ Dihexa (also known as PNB-0408)
Dihexa (also known as PNB 0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often quoted Dihexa 10mg Peptide High Purity Oligopeptide UK Peptides dihexa human studies clinical trials DHX PNB 0408 DIHEXA Peptide Synthetic Dihexa UK: Evidence Based Peptide Research Guide
Pay in 4 interest-free payments of $6.10 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5


